Entity usage

This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.

Showing below up to 50 results in range #251 to #300.

Allele-sharing among affected relatives: non-parametric methods for identifying genes: Label: en
Genetic linkage methods for quantitative traits: Label: en
Risk models in genetic epidemiology: Label: en
Family-based association studies: Label: en
Statistical designs for familial aggregation: Label: en
Introduction and overview: Label: en
An overview of group sequential methods in longitudinal clinical trials: Label: en
Statistical description of interrater variability in ordinal ratings: Label: en
Measurement error correction using validation data: a review of methods and their applicability in case-control studies: Label: en
Modelling publication bias in meta-analysis: a review: Label: en
Data mining and electroencephalography: Label: en
Data mining in brain imaging: Label: en
Knowledge discovery and data mining in toxicology: Label: en
Data mining: data analysis on a grand scale?: Label: en
Ticks and tick-borne diseases: a vector-host interaction model for the brown ear tick (Rhipicephalus appendiculatus): Label: en
Disease surveillance and data collection issues in epidemic modelling: Label: en
Modelling recurrent malaria in Thailand: Label: en
Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration: Label: en
Planning of randomized early detection trials: Label: en
Multivariate distributions of clinical covariates at the time of cancer detection: Label: en
Early detection of disease and scheduling of screening examinations: Label: en
The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing: Label: en
Power and sample size estimation in high dimensional biology: Label: en
Equivalence of conditional and marginal regression models for clustered and longitudinal data: Label: en
Identifying influential observations in discriminant analysis: Label: en
Age and stage specific prevalence estimate of cancer from population based Cancer Registry using inhomogeneous Poisson process: Label: en
Sample size requirements for the design of reliability study: review and new results: Label: en
Use of the false discovery rate for evaluating clinical safety data: Label: en
On the use of biomarkers for environmental health research: Label: en
A perspective on surrogate endpoints in controlled clinical trials: Label: en
Economic endpoints in clinical trials: Label: en
Evaluating the role of human papillomavirus vaccine in cervical cancer prevention: Label: en
Patient reported outcomes as endpoints in medical research: Label: en
Endpoints in vaccine trials: Label: en
Diagnostic test analyses in search of their gold standard: latent class analyses with random effects: Label: en
Some statistical issues in the design of HIV-1 vaccine and treatment trials: Label: en
Ethics of medical research in developing countries: the role of international codes of conduct: Label: en
Random-effects regression analysis of correlated grouped-time survival data: Label: en
Analysis of dichotomous outcome data for community intervention studies: Label: en
Components of variance in a group-randomized trial analysed via a random-coefficients model: the Rapid Early Action for Coronary Treatment (REACT) trial: Label: en
Design and analysis issues in cluster-randomized trials of interventions against infectious diseases: Label: en
Cluster randomized trials in general (family) practice research: Label: en
Exponential family models and statistical genetics: Label: en
Statistical methods in public health and epidemiology: a look at the recent past and projections for the next decade: Label: en
Medical statistics - no time for complacency: Label: en
The next 10 years of biostatistics: Label: en
Promoting good research practice: Label: en
Biostatistics in the new millennium: a consulting statistician's perspective: Label: en
Inference for non-regular parameters in optimal dynamic treatment regimes: Label: en
On model selection and model misspecification in causal inference: Label: en